Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT00966160
Eligibility Criteria:
Inclusion Criteria:
* Recent, non-acute HIV-1 infection
* Caucasians
* BMI between 17.5 and 30 kg/m2
* CD4 count \<200 cells/µl
* Plasma viral load \>100,000 HIV-1 RNA copies/ml
Exclusion Criteria:
* Actual or previous antiretroviral therapy
* Acute illness
* Coinfection with HBV or HCV
* Opportunistic infection (Pneumocystis jiroveci pneumonia, Toxoplasma gondii encephalitis, Mycobacterium ssp. infection, syphilis, cryptosporidiosis, cryptococcosis, aspergillosis, cytomegalovirus infection or progressive multifocal leukoencephalopathy)
* Hepatic or renal disorder
* Severe cardiovascular disease
* Hematologic disorder
* Autoimmune disorder
* Diabetes mellitus or other severe endocrine disorder
* Malignancy
* Neurocognitive disorder
* Psychiatric disorder
* Drug or alcohol addiction
* Chronic drug use (except of blood pressure-lowering or lipid-lowering drugs or proton-pump inhibitors)
* Any acute medication within 7 days or vaccination within 30 days prior to entry
* Pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
60 Years
Study:
NCT00966160
Study Brief:
Protocol Section:
NCT00966160